March 5, 2009 – MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, will showcase an improved administration system for TheraSphere, Yttrium-90 Microsphere (Y-90), a targeted internal radiation therapy for patients with inoperable, primary liver cancer, during the upcoming Society of Interventional Radiology 2009 (SIR 2009) scientific meeting in San Diego, CA.

The enhancements to the administration system allow for safer, faster and more efficient administration of TheraSphere, providing better treatment delivery for patients.

The simplified design of the administration system makes TheraSphere even easier to use for physicians. It has fewer parts, is easier to assemble, requires less handling, and reduces set-up time for physicians by approximately 50 per cent.

The disposable tubing and tubing connections have been re-designed to minimize barriers and optimize the fluid pathway, which is significant for delivery of small particle technology. These improvements optimize dose delivery, providing enhanced safety and ease of use for both medical staff and patients.

"Overall, MDS Nordion incorporated smart enhancements to facilitate the safe and effective delivery of TheraSphere including optimizing access to the dose vial and improving the overall internal flow of the therapy to the affected cells," said David Wood, M.D., chief of Interventional Radiology, Banner Good Samaritan Medical Center, Phoenix, AZ. "These upgrades make the administration of TheraSphere to our patients safer and easier."

May Wahab, M.D., associate professor of Radiation Oncology, Department of Radiation Oncology, Sylvester Cancer Center, Miller School of Medicine at University of Miami Hospital said that TheraSphere is the result of advanced technology allowing incorporation of radiation-emitting Yttrium into glass microbeads.

"The improvements made to the administration system will make delivering TheraSphere much easier and far more efficient and is an exciting development (for the medical community)," noted Dr. Wahab.

For more information: www.mdsnordion.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
Subscribe Now